KK
Keith Katkin (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Emergent BioSolutions Inc. (EBS). The largest single filing was $128K of EBS (15,481 sh × $8.28, as filed), executed Apr 30. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$128K
shares × price, as filed
Last traded
Apr 30
Filed May 4
Median ADV $8.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $128K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
EBS
Emergent BioSolutions Inc.
EBS · 0 buys · 1 sell
1 filing
Recent filings
EBSSALE
Emergent BioSolutions Inc.
View filing →
$128K15,481 sh × $8.28
Exec Apr 30
Filed May 4 · 5:30 PM ET